Trend Analysis of FDA Warning Letters Issued to Medical Products About Violations to Current Good Manufacturing Practices (CGMP) Between 2007 and 2014.
PMID: 30227064 · 2016
L, i, q, i, n, g, , W, a, n, g, ;, , H, a, n, g, , Z, h, e, n, g, ;, , X, i, a, o, h, o, n, g, , R, e, n, ;, , H, e, , S, u, n
広告
学術誌Therapeutic innovation & regulatory science
年2016
PMID30227064
抄録
The US Food and Drug Administration (FDA) is responsible for protecting public health. Issuance of a warning letter is the FDA's principal means of achieving prompt voluntary compliance with regulations. The objective of this study is to analyze the trends of warning letters issued to medical products about current good manufacturing practices (CGMP) violations during 2007-2014, with a secondary purpose of providing suggestions to manufacturers on how to avoid warning letters. Warning letters we
広告
公式ソース
PubMedで見る →データはPubMed / NCBIから取得しています。全文および最新情報は必ず公式記録をご確認ください。